Source: FirstWord Pharma

Niowave: Fusion Pharmaceuticals and Niowave Announce Actinium-225 Collaboration and Supply Agreement

Fusion to invest $5M for guaranteed access to actinium-225 supply Agreement augments Fusion's existing supply as company expands pipeline of actinium-based radio pharmaceuticals HAMILTON, ...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Terry Grimm's photo - Founder & CEO of Niowave

Founder & CEO

Terry Grimm

CEO Approval Rating

90/100

Read more